Transcatheter device closure of ASD has come a long way since the first experimental closure in dogs by Kings and Mills in 1972. However, unlike earlier devices, the current generation is easier to deploy and retrieve. The secret to a successful procedure includes meticulous planning and execution. It involves comprehensive evaluation from the point of appropriate case selection, detailed pre-and intra-procedural imaging, knowledge of various techniques of device deployment, and anticipating complications and ways to deal with them. In this paper, we describe the step-bystep procedure for transcatheter closure of an atrial septal defect using the Amplatzer Septal Occluder.
Stop-flow technique: The sizing balloon is placed across the ASD and inflated until there is stoppage of flow across the defect on color-flow Doppler imaging. The maximum width of the balloon is then measured on TTE/TEE/ICE as well as fluoroscopy.
Waist measurement technique: The sizing balloon is placed across the ASD and inflated until there is a waist formation noted along both the margins of the balloon on fluoroscopy. This waist is then measured on fluoroscopy.
Slide # 26:
The HELEX R Septal Occluder (W.L: Gore & Associates, Flagstaff, Arizona, USA) is a soft and compliant, non-self-centering device made from a single-length nitinol wire shaped into the left and right atrial discs covered by a polytetraflouroethylene (ePTFE) membrane. The membrane is treated with a hydrophilic coating to facilitate echocardiographic imaging of the occluder during implantation. When fully deployed, the occluder assumes a double disc configuration that bridges the septal defect to prevent shunting of blood between the right and left atria ( Figure 1 : Panel A). The HELEX R Septal Occluder received FDA clearance in 2006. The HELEX R Septal Occluder, a new device, is the result of an extended development and improvement of the HELEX R Septal Occluder. The wire frame is formed from five wires shaped into the right and left atrial discs, the eyelets, and the lock loop. The five-wire design provides conformability, allowing each individual wire within a right or left atrial disc to conform to the heart anatomy. Device release is a two staged process, firstly locking of the device by the lock loop and then removal of the retrieval cord ( Figure 1 : Panel B). A 2:1 ratio between the device size and the defect size "balloon-stretched diameter" is used for optimal results, and the device diameter should not exceed 90% of the measured septal length. The device is available in sizes of 15, 20, 25, 30 , and 35 mm.
Top right: TEE at 40 degrees (aortic short axis view), depicting the retroaortic and the postero-superior margins (Video 4).
Bottom: TEE at 90 degrees (bicaval view) demonstrates the superior vena caval and inferior vena caval margins (Video 5). When fully deployed, the occluder assumes a double disc configuration that bridges the septal defect to prevent shunting of blood between the right and left atria. Panel B. Device release is a two staged process, firstly locking of the device by the lock loop and then removal of the retrieval cord.
Advantages:
1. No reported incidence of device erosion or cardiac perforation. 2. Even after locking the device in position after optimal position is confirmed, it can still be retrieved with the help of retrieval cord attached to the right atrial disc. 3. The HELEX R Septal Occluder is a non-self-centering device having a narrow mid portion that makes it suitable for closure of multifenestrated defects. 4. The device can easily be seen on fluoroscopy and echocardiography.
Disadvantages:
1. Defects larger than 18 mm cannot be closed with this device. 2. Wire frame fracture has been reported with the HELEX R Septal Occluder, especially the larger sizes, occurring in 6.4-8.0% after 1 year [12] . 3. In a United States multicentre study of the HELEX R Septal Occluder, used in 143 patients for closure of ASDs, there was a rate of residual leaks of 25.7% at 12 months [13] . 4. There is a fixed right angle between the tip of the delivery catheter and the device. In some cases, especially in children, this distorts the anatomy and orientation of the atrial septum, making it difficult to decide whether the occluder position is optimal. With release of the device there is a pronounced repositioning when the force from the delivery system is taken away from the septum.
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The Occlutech Figulla Flex II (Occlutech GmbH, Jena, Germany) is a self-expanding nitinol wire mesh, very similar to the Amplatzer device in shape, but with a different design that eliminates the left atrial microscrew (left figure) . The device, developed using a unique patented braiding technique, consists of a nitinol wire mesh to create a smooth and flexible outer layer. Two retention discs allow for a single central pin on the right atrial side. Two polyethylene terephthalate (PET) patches assure complete closure after implantation. Available sizes range between 4 to 40 mms.
Advantages:
1. There is a 50% reduction of meshwork material on the left atrial side along with elimination of the left atrial disc microsrew, minimizing both the risk of thrombus formation and damage to the distal wall of the left atrium during implantation. 2. The delivery cable mechanism is different and allows pivoting of the device (up to 50 0 ), which facilitates positioning across the septum; an advantageous feature especially in large defects and borderline length of rims (right figure). 3. The device is fully recapturable and repositionable.
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The Amplatzer Septal Occluder device (St. Jude, Plymouth, Minnesota, USA) is a self-expandable double-disk device made of a nitinol (55% nickel; 45% titanium) wire mesh. The ASO device is constructed from a 0.004-0.0075-inch nitinol wire mesh that is tightly woven into two flat disks. There is a 3-4-mm connecting waist between the two disks, corresponding to the thickness of the atrial septum.
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*This will be in context of Amplatzer Septal Occluder (St. Jude, Plymouth, Minnesota, USA).
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These sheath sizes are recommended by the manufacturer depending on the size of the device. Our practice is to use a sheath 1 Fr larger than the recommended size excepting in children weighing less than 15 kg in whom we use the same size as per the recommendations.
*A 40-mm device is not available in the US.
Slide # 31:
A. Loader -used to introduce the Amplatzer Septal Occluder into the delivery sheath. B. Hemostatic valve with extension tube and stopcock -allows flushing the delivery system and controls back-bleeding. C. Delivery sheath -provides a pathway through which a device is delivered.
D. Dilator -used to ease penetration of skin and the subcutaneous tissue. E. Delivery cable -the device is screwed onto the distal tip of the delivery cable, which allows for placement (and if necessary, retrieval) of the device. F. Plastic vise -attached to the delivery cable, serving as a "handle" for detaching (unscrewing) the delivery cable from the device.
Slide # 32:
All the components of the delivery system are thoroughly flushed and wiped from outside with heparinized saline solution (Video 6).
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It is necessary to load the device after gently messaging it in heparinized saline so as to get rid of the air that might have been trapped in the Dacron patches. It is always a good habit to double check that the device is screwed onto the cable securely (Video 7). It is necessary to load the device after gently messaging it in heparinized saline so as to get rid of the air that might have been trapped in the Dacron patches. It is always a good habit to double check that the device is screwed onto the cable securely. View supplementary video at http://dx.doi.org/10.12945/j. jshd.2016.007.14.vid.07.
Video 8.
The ASO is slenderized within the loader followed by thorough flushing to get rid of the air within the system. View supplementary video at http://dx.doi.org/10.12945/j. jshd.2016.007.14. vid.08. 
Slide # 34:
The ASO being slenderized within the loader followed by thorough flushing to get rid of the air within the system (Video 8). 
Slide # 37:
Top left frame: Delivery sheath is advanced over the dilator into the mouth of LSPV (Video 13).
Top right frame: The delivery sheath positioned in the left atrium just outside the LSPV (Video 14). 
Slide # 38:
Dilator is removed from the sheath to allow back bleed and prevent air embolism. If the patient is under GA with positive-pressure ventilation, one can back bleed as shown in this movie; but if the patient is breathing spontaneously, it is better to back bleed by holding the sheath below the level of the heart in a saline bowl. This helps in preventing inadvertent sucking of air into the sheath resulting in air embolism (Video 16). Right frame: Corresponding TEE loop depicting deployment of the ASO across the defect (Video 23).
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TEE loops at 0 (top left), 45 (top right), and 90 degrees (bottom), confirming adequate capture of all margins before releasing the device from the loading cable (Videos 24, 25, and 26, respectively).
Slide # 43:
Left frame: Release of the ASO from loading cable in left anterior oblique (LAO) view. Note the well-separated disks of the ASO in LAO view confirming a well-positioned device (Video 27).
Right frame: Final position of the device in anteroposterior projection; fluroscopic "fingerprinting" of the device (Video 28).
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Top frames and bottom left frame: TEE loops depicting a large ASD in a small child. The left atrium is relatively smaller compared to the right atrium (Videos 29, 30, and 31).
Bottom right frame: TEE depicting the left atrial disk lying perpendicular to the atrial septum due to inability to accommodate the disk in the left atrium (Video 32).
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Left frame: ASO being deployed via LSPV technique that is engaging the LA disk into LSPV. The LA disk disengagement was spontaneous (Video 33). Similarly the left atrial disc can be engaged in the right superior pulmonary vein or the left atrial appendage.
Right frame: Corresponding TEE loop depicting the LSPV technique (Video 34).
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Left frame: If the LA disk does not disengage spontaneously, there is a tendency to pull on the loading cable to disengage the disk. In doing so, the RA disk tends to lose its alignment with the IAS and the LA disk tends to fall through the defect in the RA. We have used a contrarian technique of pushing on the cable rather than pulling, to disengage the LA disk. This creates a secondary torque on the LA disc, resulting in its disengagement from the LSPV while maintaining the alignment of the right atrial disk with the interatrial septum (Video 35).
Video 37. ASO is deployed with the left atrial disk engaged in the left atrial appendage. Similar to the previous case, the LA disk has been disengaged from the LA appendage by pushing the loading cable. View supplementary video at http://dx.doi. org/10.12945/j.jshd.2016.007.14.vid.37. Middle frame: ASO is deployed with the left atrial disk engaged into the right superior pulmonary vein. Loading cable is pushed to disengage the let atrial disk from the RSPV (Video 36).
Right frame: ASO is deployed with the left atrial disk engaged in the left atrial appendage. Similar to the previous case, the LA disk has been disengaged from the LA appendage by pushing the loading cable (Video 37).
Slide # 51:
Left frame: The delivery sheath has been positioned outside the right superior pulmonary vein instead of LSPV to prevent malalignment of the device disks with the interatrial septum (Video 38).
Right frame: The ASO device is deployed by this technique (Video 39).
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Left frame: Hausdorf sheath (Cook, Bloomington, Indiana, USA) is a specially designed long sheath with two posterior curves at its end, allowing for a better alignment of the left atrial disk parallel to the septum [16] .
Right frame: Sidecutting sheath is a modified Mullins sheath with the creation of a bevel at the inner curvature, also allowing a more parallel alignment of the left atrial disk to the interatrial septum [17] .
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Wahab technique (Dilator-assisted technique): Following deployment of the left atrial disk, a long dilator is advanced into the left atrium, holding the anterosuperior part of the left atrial disk to prevent it from prolapsing [18] .
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*Balloon assisted technique [19] : Left frame: An Occlutech balloon (Boston Scientific, Watertown, Massachusetts, USA) is positioned in the right atrium and pushed against the interatrial septum over a Superstiff wire positioned in the LSPV. The ASO delivery sheath is positioned in the right superior pulmonary vein (Video 40). Middle frame: The balloon is inflated followed by sequential release of the left atrial disk, waist and the right atrial disk (Video 41).
Right frame: The balloon is gradually deflated to allow deployment of the device across the ASD (Video 42). The advantages of BAT are that it is a simple and safe procedure, is effective across all ages, has a short learning curve and is predictable. Its limitations include requiring an additional venous access, additional hardware (cost), need for additional personnel, large venous access and problems pertaining to hemostasis.
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Left frame: The balloon catheter is pulled back into the inferior vena cava before releasing the device (Video 43).
Middle frame: The Superstiff wire now pulled back into the inferior vena cava before releasing the device (Video 44).
Right frame: Device position confirmed in left anterior oblique view and released (Video 45).
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BAT modification by Kammache et al. [20] : Major differences in this modified technique include:
1. The sizing balloon (Meditech, Boston Scientific, Watertown, Massachusetts, USA) is positioned in the septal defect or even within the left atrium in order to use it as a rim to anchor the device. 2. The left atrial disk is delivered in the left atrium rather than just outside the superior pulmonary vein. 3. The authors recommend gentle tug on the delivery cable (Minnesota wiggle) to ascertain secure device position since the balloon, and not the rim, is used as a support during device deployment.
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BAT modification by Wahab et al. [21] : This technique utilizes a regular sizing balloon that is positioned across the atrial septal defect to prevent prolapse of the left atrial disk. 
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Device embolization: -Rare complication (0.55%) [24] -Usually occurs in those with large ASD and deficient rims. Can embolize to either side of the atrial septum (left frame: ASO embolized to the right ventricle; Video 46) -Majority do not cause acute hemodynamic collapse -Most can be snared and retrieved percutaneously (right frame: ASO being retrieved from the descending thoracic aorta; Video 47); principles of percutaneous device retrieval have been well described in the literature [25] Slide # 68:
Use of ultrasound contrast agent during echocardiography can help diagnose cardiac erosion. The above video depicts absence of leak of contrast agent into the pericardial space after appearing in all the four cardiac chambers (Video 48). Patient was managed medically with close supervision to observe for any evidence of hemodynamic compromise or increase in the amount of pericardial effusion. The effusion reduced gradually followed by complete disappearance on medical management.
